|
BRIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1626000162579E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28890000023519E-07 |
| Normal-vs-Stage2 |
4.421800E-02 |
| Normal-vs-Stage3 |
1.58230000002479E-06 |
| Normal-vs-Stage4 |
1.366380E-01 |
| Stage1-vs-Stage2 |
4.062400E-01 |
| Stage1-vs-Stage3 |
1.558270E-03 |
| Stage1-vs-Stage4 |
2.149200E-01 |
| Stage2-vs-Stage3 |
3.773000E-01 |
| Stage2-vs-Stage4 |
2.951000E-01 |
| Stage3-vs-Stage4 |
3.953600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98219999969496E-07 |
| Normal-vs-AfricanAmerican |
7.431400E-04 |
| Normal-vs-Asian |
6.836500E-02 |
| Caucasian-vs-AfricanAmerican |
1.994380E-01 |
| Caucasian-vs-Asian |
8.581800E-01 |
| AfricanAmerican-vs-Asian |
3.812400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99089999997071E-06 |
| Normal-vs-Female |
1.42469999997452E-06 |
| Male-vs-Female |
3.760000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.309700E-02 |
| Normal-vs-Extreme_Weight |
1.204820E-03 |
| Normal-vs-Obese |
2.004500E-04 |
| Normal-vs-Extreme_Obese |
3.096200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.228200E-01 |
| Normal_Weight-vs-Obese |
9.655200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.944400E-02 |
| Extreme_Weight-vs-Obese |
3.712400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.514100E-02 |
| Obese-vs-Extreme_Obese |
1.298940E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.032100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.52459999997112E-06 |
| Normal-vs-Age(61-80Yrs) |
1.754370E-04 |
| Normal-vs-Age(81-100Yrs) |
5.550500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.052160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.182100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.251700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.789400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.465600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.211600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.01379999999319E-05 |
| Normal-VS-Type2 PRCC |
1.058950E-03 |
| Normal-VS-KIRP CIMP |
1.712440E-02 |
| Normal-VS-Unclassified PRCC |
1.8875099999982E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.044400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.131800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.826630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.888000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.248800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.263600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.765800E-04 |
| Normal-vs-N1 |
5.737900E-03 |
| Normal-vs-N2 |
1.811980E-01 |
| N0-vs-N1 |
2.983900E-02 |
| N0-vs-N2 |
3.377000E-01 |
| N1-vs-N2 |
7.058800E-01 |
|
|
